Humacyte Inc
NASDAQ:HUMA

Watchlist Manager
Humacyte Inc Logo
Humacyte Inc
NASDAQ:HUMA
Watchlist
Price: 1.07 USD -0.93%
Market Cap: 200.4m USD

Intrinsic Value

The intrinsic value of one HUMA stock under the Base Case scenario is 20.72 USD. Compared to the current market price of 1.07 USD, Humacyte Inc is Undervalued by 95%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HUMA Intrinsic Value
20.72 USD
Undervaluation 95%
Intrinsic Value
Price
Base Case Scenario
Compare HUMA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HUMA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Humacyte Inc

Current Assets 41.4m
Cash & Short-Term Investments 19.5m
Receivables 1.1m
Other Current Assets 20.8m
Non-Current Assets 50.2m
PP&E 49.3m
Other Non-Current Assets 881k
Current Liabilities 25.6m
Accounts Payable 9.6m
Accrued Liabilities 10.3m
Other Current Liabilities 5.7m
Non-Current Liabilities 70.7m
Long-Term Debt 27.2m
Other Non-Current Liabilities 43.5m
Efficiency

Free Cash Flow Analysis
Humacyte Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Humacyte Inc

Revenue
1.6m USD
Cost of Revenue
-620k USD
Gross Profit
951k USD
Operating Expenses
-106.3m USD
Operating Income
-105.3m USD
Other Expenses
68.3m USD
Net Income
-37m USD
Fundamental Scores

HUMA Profitability Score
Profitability Due Diligence

Humacyte Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score

Humacyte Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

HUMA Solvency Score
Solvency Due Diligence

Humacyte Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
49/100
Solvency
Score

Humacyte Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HUMA Price Targets Summary
Humacyte Inc

There are no price targets for HUMA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Humacyte Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HUMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HUMA Insider Trading
Buy and sell transactions by insiders